as on November 7, 2025 at 4:01 pm IST
Day's Low
Day's High
3.37%
Downside
3.11%
Upside
52 Week's Low
52 Week's High
54.64%
Downside
14.82%
Upside
as on November 7, 2025 at 4:01 pm IST
Market Cap
₹256.27 Cr
Return on Equity (ROE)
1.24
PE Ratio (TTM)
0Return on capital employed (ROCE)
2.99
Beta (LTM)
0.91
P/B Ratio
2.42
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-12.9
EPS (TTM)
0Sector
Healthcare
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Lotus Eye Hospital & Institute Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 256.27 | 61.74% | 0.00 | 2 | 49 | |
| NA | 61.80 | -2.3% | 0.00 | 4 | 47 | |
| NA | 35.42 | 32.49% | 0.00 | -2 | 53 | |
| NA | 31.64 | 3.1% | 0.81 | NA | 36 | |
| NA | 2,524.64 | 410.49% | 0.00 | 54 | 397 |
Search interest for Lotus Eye Hospital & Institute Ltd Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:13% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Lotus Eye Hospital & Institute Ltd.
Lotus Eye Hospital & Institute Ltd’s net profit fell -12.9% since last year same period to ₹0.54Cr in the Q1 2025-2026. On a quarterly growth basis, Lotus Eye Hospital & Institute Ltd has generated 116% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2023, Lotus Eye Hospital & Institute Ltd has declared dividend of ₹0.50 per share on 24 May 2023 - translating a dividend yield of 0.81%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, LOTUSEYE has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
Promoter Holding Up
![]()
Promoters have increased holdings from 40.39% to 40.64% in Sep 2025 quarter
Price Rise
![]()
In the last 3 months, LOTUSEYE stock has moved up by 66.9%
Against Peers
![]()
In the last 3 years, Fortis Healthcare Ltd has given 251.3% return, outperforming this stock by 175.7%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 59.58% to 59.33% in Sep 2025 quarter
| Organisation | Lotus Eye Hospital & Institute Ltd |
| Industry | Healthcare |
| CEO | Kaveetha Sundaramoorthy |
| E-voting on shares | Click here to vote |
Lotus Eye Hospital & Institute Ltd share price today stands at ₹121.23 as on at the close of the market. Lotus Eye Hospital & Institute Ltd share today touched a day high of ₹125 and a low of ₹117.15.
Lotus Eye Hospital & Institute Ltd touched a 52 week high of ₹139.2 and a 52 week low of ₹54.99. Lotus Eye Hospital & Institute Ltd share price today i.e. is closed at ₹121.23, which is -12.91% down from its 52 week high and 120.46% up from its 52 week low.
Lotus Eye Hospital & Institute Ltd market capitalisation is ₹256.27 Cr as on .
To buy Lotus Eye Hospital & Institute Ltd shares, you need to follow these steps:
Lotus Eye Hospital & Institute Ltd trading volume is 7,975.00 as on . This means that 7,975.00 shares of Lotus Eye Hospital & Institute Ltd were bought and sold on the stock market during today's trading session.